Hypertensive disorders of pregnancy and urinary tract infections: an underestimated association in comprehensive maternal care
Authors
DOI:
https://doi.org/10.37980/im.journal.revcog.es.20252698Keywords:
carta al editorAbstract
Hypertensive disorders of pregnancy (HDP) affect up to 10% of pregnancies and are associated with substantial maternal and fetal morbidity. Beyond their well-known vascular and endothelial effects, HDP may also increase susceptibility to urinary tract infections (UTIs) through immunologic and hemodynamic mechanisms. Preeclampsia, in particular, disrupts immune regulation and alters urinary composition, creating a more favorable environment for bacterial colonization by Escherichia coli and other pathogens. Several studies have reported a higher prevalence of bacteriuria and symptomatic UTI in women with preeclampsia, potentially related to physiological changes of pregnancy, impaired host defenses, or increased exposure to invasive medical procedures. Diagnosis can be challenging because UTI symptoms frequently overlap with manifestations of HDP, which may contribute to delays in treatment. Given these risks, systematic screening for bacteriuria and strengthened preventive strategies are recommended. A deeper understanding of this bidirectional relationship between HDP and UTIs is essential to optimizing prenatal care and reducing maternal-fetal complications, especially in vulnerable populations.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Infomedic Intl.Derechos autoriales y de reproducibilidad. La Revista RevCog es un ente académico, sin fines de lucro, que forma parte de la Sociedad Centroamericana de Ginecología y Obstetricia. Sus publicaciones son de tipo ACCESO GRATUITO y PERMANENTE de su contenido para uso individual y académico, sin restricción. Los derechos autoriales de cada artículo son retenidos por sus autores. Al Publicar en la Revista, el autor otorga Licencia permanente, exclusiva, e irrevocable a la Sociedad para la edición del manuscrito, y otorga a la empresa editorial, Infomedic International Licencia de uso de distribución, indexación y comercial exclusiva, permanente e irrevocable de su contenido y para la generación de productos y servicios derivados del mismo.




